Updates in diagnosis and management of paediatric mastocytosis

Area of Science:

• Pediatric Hematology
• Allergy and Immunology
• Dermatology

Background:

• Paediatric mastocytosis is a rare clonal disorder involving mast cell proliferation and infiltration, leading to symptoms from mediator release.
• Cutaneous mastocytosis is the predominant form in children; systemic disease is infrequent.
• Understanding disease subtypes is crucial for effective management.

Approach:

• This guideline provides practical recommendations for differentiating paediatric mastocytosis subtypes.
• It offers actionable advice on diagnosis, clinical management, and follow-up strategies.
• Emphasis is placed on prognosis and supporting affected children and families.

Key Points:

• Longitudinal studies indicate spontaneous remission and a favorable prognosis for paediatric cutaneous mastocytosis.
• Hereditary alpha-tryptasemia screening is advised due to potential co-occurrence.
• Serum tryptase has emerging roles in asthma endotyping, with potential for tryptase inhibitor therapies.

Conclusions:

• Morbidity often stems from mast cell mediator release; non-aggressive forms generally have a good prognosis.
• Anaphylaxis and psychosocial impacts require careful consideration and anticipatory guidance.
• Symptomatic management and proactive support are vital for patients and families.